hunter williams retatrutide vs. Cancer: New Study Shows Metabolic Drug Reduces Tumor Growth | Hunter Williams - CEO -

Clinical trials show weight loss of 15 to 22 percent of body weight, numbers that were previously only achievable with bariatric surgery

In patients with type 1 diabetes, SEMGLEE must be used concomitantly with short-acting insulin

Comparing timing strategies with other GLP-1 medications If you have previously used semaglutide or tirzepatide, your timing experience with those medications provides useful but imperfect guidance for retatrutide

Holst JJ, Andersen DB, Grunddal KV (2022) Actions of glucagon-like peptide-1 receptor ligands in the gut

By pairing medical care with the GLP-1 Success framework, Med+ delivers a complete solution that goes far beyond prescription-only servicesand drives stronger outcomes for members than medication alone

Learn what NAD+ is, how NAD+ therapy may support energy, recovery, metabolism, brain function, and healthy aging, and why it has become one of the most talked-about tools in longevity and wellness medicine